Fund Holdings — Qiming U.S. Ventures Management, LLC

Total Portfolio Value:
$109.21M
Total Bought:
$34.44M
Total Sold:
$8.24M
Net Transaction:
+$26.20M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Icosavax Inc3,510,2283,510,2280$27.20M$55.32M50.66%+$28.12M
Korro Bio, Inc.(KRRO)0368,085+368,085$0$17.64M16.15%+$17.64M
Tourmaline Bio Inc0641,691+641,691$0$16.80M15.38%+$16.80M
Hillevax Inc558,923558,9230$7.52M$8.97M8.21%+$1.45M
Jasper Therapeutics, Inc.(JSPR)8,519,6488,519,6480$5.96M$6.72M6.16%+$758.2K
Ventyx Biosciences Inc686,370686,3700$23.84M$1.70M1.55%-$22.14M
Elevation Oncology Inc2,370,1422,370,1420$1.57M$1.27M1.17%-$297.7K
Kezar Life Sciences Inc828,711828,7110$986.2K$785.1K0.72%-$201.0K
TALARIS THERAPEUTICS INCCOM2,932,6060-2,932,606$8.24M$0—-$8.24M
Page 1 of 1